Imiquimod (Perrigo New York Inc)
Welcome to the PulseAid listing for the Imiquimod drug offered from Perrigo New York Inc. This Increased Cytokine Activity [PE],Increased Cytokine Production [PE],Interferon Inducers [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Perrigo New York Inc |
NON-PROPRIETARY NAME: | Imiquimod |
SUBSTANCE NAME: | IMIQUIMOD |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Increased Cytokine Activity [PE],Increased Cytokine Production [PE],Interferon Inducers [MoA] |
ROUTE: | TOPICAL |
DOSAGE FORM: | CREAM |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2010-11-09 |
END MARKETING DATE: | 0000-00-00 |
Imiquimod HUMAN PRESCRIPTION DRUG Details:
Item Description | Imiquimod from Perrigo New York Inc |
LABELER NAME: | Perrigo New York Inc |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 12.5(mg/.25g) |
START MARKETING DATE: | 2010-11-09 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 45802-368_42c5b579-35b5-4b82-b2c8-c226e5b1a795 |
PRODUCT NDC: | 45802-368 |
APPLICATION NUMBER: | ANDA078837 |
Other IMIQUIMOD Pharmaceutical Manufacturers / Labelers: